{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T15:10:42Z","timestamp":1790262642486,"version":"4.1.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:00:00Z","timestamp":1779321600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:00:00Z","timestamp":1779321600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s00210-026-05439-x","type":"journal-article","created":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T07:55:00Z","timestamp":1779350100000},"page":"16713-16728","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Edaravone dexborneol in acute ischemic stroke: a systematic review and meta-analysis of randomized trials with clinical and thrombectomy-specific subgroup analyses"],"prefix":"10.1007","volume":"399","author":[{"given":"Eman","family":"Tariq","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hooriya","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tayyaba Ikram","family":"Qazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul","family":"Muhaimin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleena Amir","family":"Malik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javeria","family":"Soomro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahimeen","family":"Qureshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zainab","family":"Murtaza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarum Ali","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wajeeha","family":"Komal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadia","family":"Tanveer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rida","family":"Ameer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahathir","family":"Mohammad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khayyam","family":"Haider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Faaz","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haris Wazir","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasir","family":"Mehmood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asia","family":"Batool","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sajjad Ghanim","family":"Al-Badri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Huzaifa","family":"Khattak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-6397-1692","authenticated-orcid":false,"given":"Bilal Wazir","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,21]]},"reference":[{"issue":"8","key":"5439_CR1","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/S1474-4422(20)30207-6","volume":"19","author":"AFFINITY Trial Collaboration","year":"2020","unstructured":"AFFINITY Trial Collaboration (2020) Safety and efficacy of fluoxetine on functional outcome after acute stroke (AFFINITY): a randomised, double-blind, placebo-controlled trial. Lancet Neurol 19(8):651\u2013660. https:\/\/doi.org\/10.1016\/S1474-4422(20)30207-6","journal-title":"Lancet Neurol"},{"key":"5439_CR2","doi-asserted-by":"publisher","unstructured":"Chen HS, Zhao ZA, Shen XY, Qiu SQ, Cui Y, Qiu J, Li W, Zhang H, Chen WH, Wang LH, Zhang DH, Chen Y, Ma YT, Gao ZE, Wang SC, Li D, Liu H, Nguyen TN (2025) Edaravone dexborneol for ischemic stroke with sufficient recanalization after thrombectomy: a randomized phase II trial. Nat Commun 16:2393. https:\/\/doi.org\/10.1038\/s41467-025-57774-x","DOI":"10.1038\/s41467-025-57774-x"},{"key":"5439_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.848529","volume":"13","author":"Q Chen","year":"2022","unstructured":"Chen Q, Cai Y, Zhu X, Wang J, Gao F, Yang M et al (2022) Edaravone Dexborneol treatment attenuates neuronal apoptosis and improves neurological function by suppressing 4-HNE-associated oxidative stress after subarachnoid hemorrhage. Front Pharmacol 13:848529. https:\/\/doi.org\/10.3389\/fphar.2022.848529","journal-title":"Front Pharmacol"},{"key":"5439_CR4","unstructured":"Cochrane Handbook for Systematic Reviews of Interventions (n.d.) Cochrane [Internet]. [cited 2026 Mar 19]. Available from: https:\/\/www.cochrane.org\/authors\/handbooks-and-manuals\/handbook"},{"issue":"12","key":"5439_CR5","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1038\/sj.jcbfm.9600298","volume":"26","author":"U Dirnagl","year":"2006","unstructured":"Dirnagl U (2006) Bench to bedside: the quest for quality in experimental stroke research. J Cereb Blood Flow Metab Off J Int Soc Cereb Blood Flow Metab 26(12):1465\u20131478. https:\/\/doi.org\/10.1038\/sj.jcbfm.9600298","journal-title":"J Cereb Blood Flow Metab Off J Int Soc Cereb Blood Flow Metab"},{"key":"5439_CR6","unstructured":"Edaravone dexborneol for ischemic stroke with sufficient recanalization after thrombectomy: a randomized phase II trial (n.d.) PubMed [Internet]. [cited 2026 Mar 19]. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/40064868\/"},{"key":"5439_CR7","unstructured":"Edaravone dexborneol protects cerebral ischemia reperfusion injury through activating Nrf2\/HO-1 signaling pathway in mice (n.d.) PubMed [Internet]. [cited 2026 Mar 19]. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/35470467\/"},{"key":"5439_CR8","unstructured":"Effects of edaravone dexborneol on neurological function and serum inflammatory factor levels in patients with acute anterior circulation large vessel occlusion stroke (n.d.) - PMC [Internet]. [cited 2026 Mar 19]. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC10579784\/"},{"key":"5439_CR9","unstructured":"Effect of a novel free radical scavenger, edaravone (MCI-186), on acute brain infarction (n.d.) Randomized, placebo-controlled, double-blind study at multicenters - PubMed [Internet]. [cited 2026 Mar 19]. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/12715790\/"},{"key":"5439_CR10","doi-asserted-by":"publisher","unstructured":"\u00a0Fu Y, Wang A, Tang R, Li S, Tian X, Xia X, Ren J, Yang S, Chen R, Zhu S, Feng X, Yao J, Wei Y, Dong X, Ling Y, Yi F, Deng Q, Guo C, Sui Y, Han S, Wen G, Li C, Dong A, Sun X, Wang Z, Shi X, Liu B, Fan D (2024) Sublingual edaravone dexborneol for the treatment of acute ischemic stroke: the TASTE-SL randomized clinical trial. JAMA Neurol 81:357\u2013365. https:\/\/doi.org\/10.1001\/jamaneurol.2023.5716","DOI":"10.1001\/jamaneurol.2023.5716"},{"key":"5439_CR11","doi-asserted-by":"publisher","first-page":"1589307","DOI":"10.3389\/fneur.2025.1589307","volume":"16","author":"H Gao","year":"2025","unstructured":"Gao H, Tan H, Wang J, Yang D, Liu Y, Wu T (2025) Clinical efficacy of edaravone dexborneol in the treatment of acute ischemic stroke: meta-analysis. Front Neurol 16:1589307. https:\/\/doi.org\/10.3389\/fneur.2025.1589307","journal-title":"Front Neurol"},{"issue":"5","key":"5439_CR12","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/S1474-4422(19)30034-1","volume":"18","author":"GBD 2016 Stroke Collaborators","year":"2019","unstructured":"GBD 2016 Stroke Collaborators (2019) Global, regional, and national burden of stroke, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 18(5):439\u2013458. https:\/\/doi.org\/10.1016\/S1474-4422(19)30034-1","journal-title":"Lancet Neurol"},{"issue":"10","key":"5439_CR13","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/S1474-4422(21)00252-0","volume":"20","author":"GBD 2019 Stroke Collaborators","year":"2021","unstructured":"GBD 2019 Stroke Collaborators (2021) Global, regional, and national burden of stroke and its risk factors, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Neurol 20(10):795\u2013820. https:\/\/doi.org\/10.1016\/S1474-4422(21)00252-0","journal-title":"Lancet Neurol"},{"issue":"10029","key":"5439_CR14","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1016\/S0140-6736(16)00163-X","volume":"387","author":"M Goyal","year":"2016","unstructured":"Goyal M, Menon BK, van Zwam WH, Dippel DWJ, Mitchell PJ, Demchuk AM et al (2016) Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials. Lancet 387(10029):1723\u20131731. https:\/\/doi.org\/10.1016\/S0140-6736(16)00163-X","journal-title":"Lancet"},{"issue":"13","key":"5439_CR15","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1056\/NEJMoa0804656","volume":"359","author":"W Hacke","year":"2008","unstructured":"Hacke W, Kaste M, Bluhmki E, Brozman M, D\u00e1valos A, Guidetti D et al (2008) Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 359(13):1317\u20131329. https:\/\/doi.org\/10.1056\/NEJMoa0804656","journal-title":"N Engl J Med"},{"issue":"7414","key":"5439_CR16","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JPT Higgins","year":"2003","unstructured":"Higgins JPT, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327(7414):557\u2013560. https:\/\/doi.org\/10.1136\/bmj.327.7414.557","journal-title":"BMJ"},{"issue":"10227","key":"5439_CR17","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/S0140-6736(20)30258-0","volume":"395","author":"MD Hill","year":"2020","unstructured":"Hill MD, Goyal M, Menon BK, Nogueira RG, McTaggart RA, Demchuk AM et al (2020) Efficacy and safety of nerinetide for the treatment of acute ischaemic stroke (ESCAPE-NA1): a multicentre, double-blind, randomised controlled trial. Lancet 395(10227):878\u2013887. https:\/\/doi.org\/10.1016\/S0140-6736(20)30258-0","journal-title":"Lancet"},{"key":"5439_CR18","doi-asserted-by":"publisher","unstructured":"Hu X, Qian Z, Chen J, Chen M, Zhong W, Shen C, Hu Z, Li R (2023) Effects of edaravone dexborneol onneurological function and serum inflammatory factor levels in patients with acute anterior circulation large vessel occlusion stroke. Transl Neurosci 14:20220312. https:\/\/doi.org\/10.1515\/tnsci-2022-0312","DOI":"10.1515\/tnsci-2022-0312"},{"issue":"5","key":"5439_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11051162","volume":"11","author":"A Honig","year":"2022","unstructured":"Honig A, Percy J, Sepehry AA, Gomez AG, Field TS, Benavente OR (2022) Hemorrhagic transformation in acute ischemic stroke: a quantitative systematic review. J Clin Med 11(5):1162. https:\/\/doi.org\/10.3390\/jcm11051162","journal-title":"J Clin Med"},{"key":"5439_CR20","unstructured":"Ischemia\/reperfusion injury in acute human and experimental stroke: focus on thrombo-inflammatory mechanisms and treatments (n.d.) PMC [Internet]. [cited 2026 Mar 19]. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC11587771\/"},{"issue":"8","key":"5439_CR21","doi-asserted-by":"publisher","first-page":"9569","DOI":"10.1007\/s00210-025-03950-1","volume":"398","author":"M Kashbour","year":"2025","unstructured":"Kashbour M, Shata A, Wagdy M, Alnajjar AZ, Aldemerdash MA, Tarakhan H et al (2025) Efficacy and safety of edaravone dexborneol in acute ischemic stroke: systematic review and meta-analysis of randomized controlled trials. Naunyn Schmiedebergs Arch Pharmacol 398(8):9569\u20139582. https:\/\/doi.org\/10.1007\/s00210-025-03950-1","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"5439_CR22","doi-asserted-by":"publisher","unstructured":"Khan BW, Khan HW, Khattak MH, Shaheer M, Qazi TI, Khan MF, Dawer P, Khan UZ, Idrees S, Khan AS (2026) Efficacy and safety of tirofiban combined with intravenous thrombolysis in acute ischemic stroke: a GRADE-assessed systematic review and meta-analysis of randomized controlled trials and observational studies. Neurol Res: 1\u201318. https:\/\/doi.org\/10.1080\/01616412.2026.2648166","DOI":"10.1080\/01616412.2026.2648166"},{"issue":"10","key":"5439_CR23","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1517\/14656566.2010.493558","volume":"11","author":"PA Lapchak","year":"2010","unstructured":"Lapchak PA (2010) A critical assessment of edaravone acute ischemic stroke efficacy trials: is edaravone an effective neuroprotective therapy? Expert Opin Pharmacother 11(10):1753\u20131763. https:\/\/doi.org\/10.1517\/14656566.2010.493558","journal-title":"Expert Opin Pharmacother"},{"issue":"1","key":"5439_CR24","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.56535","volume":"8","author":"JS Lee","year":"2025","unstructured":"Lee JS, Kang HG, Ahn SH et al (2025) Nelonemdaz and patients with acute ischemic stroke and mechanical reperfusion: the RODIN randomized clinical trial. JAMA Netw Open 8(1):e2456535. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.56535","journal-title":"JAMA Netw Open"},{"issue":"1","key":"5439_CR25","doi-asserted-by":"publisher","first-page":"e044296","DOI":"10.1161\/JAHA.125.044296","volume":"15","author":"G Ma","year":"2026","unstructured":"Ma G, Raynald, Arham A, Jiang Z, Mo R, Zuo Y et al (2026) Edaravone Dexborneol in Large Ischemic Stroke: Real-World Experience from a Multicenter Study in China. J Am Heart Assoc 15(1):e044296. https:\/\/doi.org\/10.1161\/JAHA.125.044296","journal-title":"J Am Heart Assoc"},{"issue":"9","key":"5439_CR26","doi-asserted-by":"publisher","first-page":"2355","DOI":"10.1161\/STROKEAHA.116.012825","volume":"47","author":"RH Martin","year":"2016","unstructured":"Martin RH, Yeatts SD, Hill MD, Moy CS, Ginsberg MD, Palesch YY (2016) ALIAS (Albumin in acute ischemic stroke) trials: analysis of the combined data from Parts 1 and 2. Stroke 47(9):2355\u20132359. https:\/\/doi.org\/10.1161\/STROKEAHA.116.012825","journal-title":"Stroke"},{"key":"5439_CR27","unstructured":"Meta-analysis in clinical trials (n.d.) PubMed [Internet]. [cited 2026 Mar 19]. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/3802833\/"},{"key":"5439_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2025.1649476","volume":"16","author":"K Moghib","year":"2025","unstructured":"Moghib K, Hefnawy MT, Moawad SM, Salomon I, Hamdi A, Uwishema O et al (2025) Efficacy and safety of edaravone dexborneol in acute ischemic stroke: systematic review and meta-analysis. Front Neurol 16:1649476. https:\/\/doi.org\/10.3389\/fneur.2025.1649476","journal-title":"Front Neurol"},{"issue":"8","key":"5439_CR29","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1093\/brain\/awx126","volume":"140","author":"AA Neuhaus","year":"2017","unstructured":"Neuhaus AA, Couch Y, Hadley G, Buchan AM (2017) Neuroprotection in stroke: the importance of collaboration and reproducibility. Brain J Neurol 140(8):2079\u20132092. https:\/\/doi.org\/10.1093\/brain\/awx126","journal-title":"Brain J Neurol"},{"issue":"3","key":"5439_CR30","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1002\/ana.20741","volume":"59","author":"VE O\u2019Collins","year":"2006","unstructured":"O\u2019Collins VE, Macleod MR, Donnan GA, Horky LL, van der Worp BH, Howells DW (2006) 1,026 experimental treatments in acute stroke. Ann Neurol 59(3):467\u2013477. https:\/\/doi.org\/10.1002\/ana.20741","journal-title":"Ann Neurol"},{"key":"5439_CR31","unstructured":"Progress in Borneol Intervention for Ischemic Stroke: A Systematic Review (n.d.) PubMed [Internet]. [cited 2026 Mar 19]. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/34017247\/"},{"key":"5439_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/00207454.2026.2628832","volume":"16","author":"H Sabet","year":"2026","unstructured":"Sabet H, Abbas A, Zanaty MA, Elyamany Z, El-Moslemani M, Pereira MAOM et al (2026) Evaluating the efficacy and safety of Edaravone-Dexborneol in acute ischemic stroke: an updated systematic review and meta-analysis of 7,846 Chinese patients. Int J Neurosci 16:1\u201316. https:\/\/doi.org\/10.1080\/00207454.2026.2628832","journal-title":"Int J Neurosci"},{"issue":"6","key":"5439_CR33","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1056\/NEJMoa1408827","volume":"372","author":"JL Saver","year":"2015","unstructured":"Saver JL, Starkman S, Eckstein M, Stratton SJ, Pratt FD, Hamilton S, Conwit R et al (2015) Prehospital use of magnesium sulfate as neuroprotection in acute stroke. N Engl J Med 372(6):528\u2013536. https:\/\/doi.org\/10.1056\/NEJMoa1408827","journal-title":"N Engl J Med"},{"issue":"1","key":"5439_CR34","doi-asserted-by":"publisher","first-page":"3","DOI":"10.4103\/ds.DS-D-22-00154","volume":"41","author":"SC Shao","year":"2023","unstructured":"Shao SC, Kuo LT, Huang YT, Lai PC, Chi CC (2023) Using Grading of Recommendations Assessment, Development, and Evaluation (GRADE) to rate the certainty of evidence of study outcomes from systematic reviews: a quick tutorial. Dermatol Sin 41(1):3\u20137. https:\/\/doi.org\/10.4103\/ds.DS-D-22-00154","journal-title":"Dermatol Sin"},{"issue":"6","key":"5439_CR35","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1056\/NEJMoa070240","volume":"357","author":"A Shuaib","year":"2007","unstructured":"Shuaib A, Lees KR, Lyden P, Grotta J, Davalos A, Davis SM et al (2007) NXY-059 for the treatment of acute ischemic stroke. N Engl J Med 357(6):562\u2013571. https:\/\/doi.org\/10.1056\/NEJMoa070240","journal-title":"N Engl J Med"},{"key":"5439_CR36","unstructured":"Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke (n.d.) PubMed [Internet]. [cited 2026 Mar 19]. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/25882376\/"},{"key":"5439_CR37","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l4898","volume":"366","author":"JAC Sterne","year":"2019","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ, Elbers RG, Blencowe NS, Boutron I et al (2019) RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ 366:l4898. https:\/\/doi.org\/10.1136\/bmj.l4898","journal-title":"BMJ"},{"key":"5439_CR38","doi-asserted-by":"publisher","unstructured":"Wang C, Gu H, Huo X, Yuan B, Li S, Xu J, Jiang Y, Jing J, Yao X, Li Z, Long F, Ma Z, Zhuang X, Xu L, Jin Y,Huang W, Zhang Y, Wen J, Wang A, Pan Y, Ye W, Yu W, Cheng A, Wang M, Dong Q, Xu A, Wang N, Yang Y, Meng X, LiuL, Zhao X, Li H, Miao Z, Li Z, Wang Y (2026) Edaravone dexborneol versus placebo on functional outcomes in patients with acute is chaemic stroke undergoing endovascular thrombectomy (TASTE-2): randomised controlled trial. BMJ392:e086850. https:\/\/doi.org\/10.1136\/bmj-2025-086850","DOI":"10.1136\/bmj-2025-086850"},{"key":"5439_CR39","doi-asserted-by":"publisher","unstructured":"Xu J, Wang Y, Wang A, Gao Z, Gao X, Chen H, Zhou J, Zhao X, Wang Y (2019) Safety and efficacy of edaravone dexborneol versus edaravone for patients with acute ischaemic stroke: a phase II, multicentre, randomised, double-blind, multiple-dose, active-controlled clinical trial. Stroke Vasc Neurol 4:109\u2013114. https:\/\/doi.org\/10.1136\/svn-2018-000221","DOI":"10.1136\/svn-2018-000221"},{"issue":"3","key":"5439_CR40","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1161\/STROKEAHA.120.031197","volume":"52","author":"J Xu","year":"2021","unstructured":"Xu J, Wang A, Meng X, Yalkun G, Xu A, Gao Z et al (2021) Edaravone dexborneol versus edaravone alone for the treatment of acute ischemic stroke: a phase III, randomized, double-blind. Comparative Trial Stroke 52(3):772\u2013780. https:\/\/doi.org\/10.1161\/STROKEAHA.120.031197","journal-title":"Comparative Trial Stroke"},{"key":"5439_CR41","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2024.1451060","volume":"18","author":"M Xu","year":"2024","unstructured":"Xu M, Li L, Xu B, Yuan S, Zheng Q, Sun W (2024) Observations on the efficacy of edaravone dexborneol in preventing post-stroke depression and its inflammatory mechanism: a prospective, randomized, control trial. Front Neurosci 18:1451060. https:\/\/doi.org\/10.3389\/fnins.2024.1451060","journal-title":"Front Neurosci"},{"key":"5439_CR42","doi-asserted-by":"publisher","unstructured":"Zhou X, Shu ZG, Liu SC, Li DZ (2025) Eff ect of edaravone dexborneol combined with interventional thrombectomy on nerve function, cerebral hemodynamics, and serum levels of serum amyloid A, lipoprotein-associated phospholipase A2, and soluble CD40 ligand in elderly patients with ischemic stroke. J Physiol Pharmacol 76:31\u201338. https:\/\/doi.org\/10.26402\/jpp.2025.1.03","DOI":"10.26402\/jpp.2025.1.03"},{"issue":"5","key":"5439_CR43","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1007\/s12975-024-01319-9","volume":"16","author":"W Zhu","year":"2025","unstructured":"Zhu W, He X, Huang D, Jiang Y, Hong W, Ke S et al (2025) Global and regional burden of ischemic stroke disease from 1990 to 2021: an age-period-cohort analysis. Transl Stroke Res 16(5):1474\u20131485. https:\/\/doi.org\/10.1007\/s12975-024-01319-9","journal-title":"Transl Stroke Res"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05439-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-026-05439-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05439-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T13:02:34Z","timestamp":1787662954000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-026-05439-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,21]]},"references-count":43,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["5439"],"URL":"https:\/\/doi.org\/10.1007\/s00210-026-05439-x","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,21]]},"assertion":[{"value":"20 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that all data were generated in-house, that no paper mill was used and that no AI tool has been used for the generation of text or figures except for minor language and flow improvements to improve readability.","order":1,"name":"Ethics","label":"Declaration of AI Use","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not Applicable.","order":2,"name":"Ethics","label":"Clinical trial number","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not Applicable.","order":3,"name":"Ethics","label":"Human ethics and consent to participate declarations","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was not required for this systematic review and meta-analysis.","order":4,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":5,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":6,"name":"Ethics","label":"Informed consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":7,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}